Truong, Jacob X. M.
Spotbeen, Xander
White, Jake
Swinnen, Johannes V.
Butler, Lisa M.
Snel, Marten F.
Trim, Paul J. http://orcid.org/0000-0001-8734-3433
Funding for this research was provided by:
U.S. Department of Defense (W81XWH190566)
Movember Foundation/Prostate Cancer Foundation of Australia (MRTA3)
Article History
Received: 23 September 2020
Revised: 27 November 2020
Accepted: 15 December 2020
First Online: 9 February 2021
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest.
: Approval for the use of human prostate cancer tissues was granted by the Ethics Committees of the University of Adelaide (Adelaide, Australia) (approval number H-2018-222) and St Andrew’s Hospital (Adelaide Australia). The use of prostate xenograft tissues was approved by the Animal Ethics Committee of the University of Adelaide (Adelaide, Australia) (approval number M-2019-037).
: Human prostate cancer tissues were obtained from patients undergoing radical prostatectomies and were provided by the Australian Prostate Cancer BioResource (Adelaide Australia). Prostate xenograft tissues were obtained from another study conducted by the University of Adelaide [CitationRef removed].
: N/A
: Not applicable.
: Not applicable.
: Not applicable.